NO962125D0 - Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor - Google Patents

Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor

Info

Publication number
NO962125D0
NO962125D0 NO962125A NO962125A NO962125D0 NO 962125 D0 NO962125 D0 NO 962125D0 NO 962125 A NO962125 A NO 962125A NO 962125 A NO962125 A NO 962125A NO 962125 D0 NO962125 D0 NO 962125D0
Authority
NO
Norway
Prior art keywords
induce
growth factor
immune response
factor receptor
epidermal growth
Prior art date
Application number
NO962125A
Other languages
English (en)
Other versions
NO962125L (no
Inventor
Ana Carceller
Elisabet Rosell
Enrique Gomez
Jaume Adan
Jaume Piulats
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO962125D0 publication Critical patent/NO962125D0/no
Publication of NO962125L publication Critical patent/NO962125L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO962125A 1995-05-26 1996-05-24 Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor NO962125L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95107967 1995-05-26

Publications (2)

Publication Number Publication Date
NO962125D0 true NO962125D0 (no) 1996-05-24
NO962125L NO962125L (no) 1996-11-27

Family

ID=8219291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962125A NO962125L (no) 1995-05-26 1996-05-24 Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor

Country Status (15)

Country Link
US (1) US5969107A (no)
JP (1) JPH08325299A (no)
KR (1) KR960040375A (no)
CN (1) CN1142505A (no)
AT (1) ATE208403T1 (no)
AU (1) AU710159B2 (no)
CA (1) CA2177328A1 (no)
CZ (1) CZ289357B6 (no)
DE (1) DE69616651D1 (no)
HU (1) HUP9601392A3 (no)
MX (1) MX9601930A (no)
NO (1) NO962125L (no)
PL (1) PL314414A1 (no)
SK (1) SK67496A3 (no)
ZA (1) ZA964207B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109306010A (zh) * 2017-07-26 2019-02-05 石家庄以岭药业股份有限公司 表皮生长因子受体抗体及其用途

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924359B1 (en) * 1999-07-01 2005-08-02 Yale University Neovascular-targeted immunoconjugates
DK1358318T3 (da) * 2001-02-07 2007-01-02 Wilex Ag Hybridomcellelinje G250 og dens anvendelse til frembringelse af monoklonale antistoffer
WO2003092693A1 (en) * 2002-05-06 2003-11-13 Washington University Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
KR101531400B1 (ko) 2003-06-27 2015-06-26 암젠 프레몬트 인코포레이티드 상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그용도
CA2671585A1 (en) * 2006-12-22 2008-07-03 Novelix Therapeutics Gmbh Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof
WO2011097633A2 (en) * 2010-02-08 2011-08-11 Board Of Regents, The University Of Texas System Egf receptor mimicking peptides
EP2663579B1 (en) 2011-01-14 2017-04-26 The Regents of the University of California Therapeutic antibodies against ror-1 protein and methods for use of same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (en) * 1983-11-07 1993-06-16 The Wistar Institute Immune response to tumours and viruses induced by anti-idiotype antibodies
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US5459061A (en) * 1990-01-26 1995-10-17 W. Alton Jones Cell Science Center, Inc. Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor
CZ282603B6 (cs) * 1991-03-06 1997-08-13 Merck Patent Gesellschaft Mit Beschränkter Haftun G Humanizované a chimerické monoklonální protilátky
US5344760A (en) * 1991-06-03 1994-09-06 Ciba Corning Diagnostics Corp. Method of cancer detection
DE69327620T2 (de) * 1992-08-18 2000-08-03 Centro De Immunologia Molecular, Ciudad De La Habana Monoklonale Antikörper gegen den epidermalen Wachstumsfaktorrezeptor, Zellen und Verfahren zur ihrer Herstellung und sie erhaltende Zusammensetzungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109306010A (zh) * 2017-07-26 2019-02-05 石家庄以岭药业股份有限公司 表皮生长因子受体抗体及其用途
CN109306010B (zh) * 2017-07-26 2022-07-19 石家庄以岭药业股份有限公司 表皮生长因子受体抗体及其用途

Also Published As

Publication number Publication date
CA2177328A1 (en) 1996-11-27
HU9601392D0 (en) 1996-07-29
ATE208403T1 (de) 2001-11-15
PL314414A1 (en) 1996-12-09
HUP9601392A3 (en) 2000-08-28
SK67496A3 (en) 1996-12-04
CZ152596A3 (en) 1996-12-11
JPH08325299A (ja) 1996-12-10
MX9601930A (es) 1997-01-31
US5969107A (en) 1999-10-19
HUP9601392A2 (en) 1997-03-28
ZA964207B (en) 1996-12-04
AU710159B2 (en) 1999-09-16
KR960040375A (ko) 1996-12-17
DE69616651D1 (de) 2001-12-13
AU5242296A (en) 1996-12-05
NO962125L (no) 1996-11-27
CZ289357B6 (cs) 2002-01-16
CN1142505A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
DE69429095D1 (de) Humanisierte antikoerper
CA2056102A1 (en) Method for the production of antibodies
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
IL132249A0 (en) Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
ATE531812T1 (de) Humanisierung von nager-antikörpern
DK0380068T3 (da) Ekspressionssystem til fremstilling af kimære monoklonale antistoffer
NO962125D0 (no) Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ATE307208T1 (de) Pseudomonas exotoxin-a-ähnliche chimerische immunogene
DE69836024D1 (de) Pseudomonas exotoxin a-ähnliche chimerische immunogene zum auslösen einer sekretorischen iga-vermittelten immunantwort
AU4441393A (en) Granulocyte-binding antibody fragments, their preparation and use
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
IT1277827B1 (it) Anticorpo monoclonale chimerico murino/umano o un suo frammento specifico per il recettore egf (egf-r)
DE69024758D1 (de) Neuartige antiidiotypische monoklonale Antikörper
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
BR0307308A (pt) Antìgenos de superfìcies larvais nematóides
CA2107329A1 (en) Anti-Human Immunodeficiency Virus Recombinant Antibodies
WO2003097663A3 (de) Immunogener, monoklonaler antikörper, der mindestens 2 verschiedene epitope ines tumor-assoziierten antigens aufweist
WO1992004464A3 (en) Monoclonal antibodies against tenascin
BR1100555B1 (pt) anticorpos monoclonais humanizados.
NO900092L (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application